TrialMolecular cancer2026

Adjuvant recombinant human endostatin combined with toripalimab (anti-PD-1) in locally advanced melanoma: an exploratory phase 2 clinical trial incorporating single-cell RNA/TCR/BCR sequencing.

Xianglin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.